Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EXACT Therapeutics AS ( (DE:56F) ) has shared an update.
EXACT Therapeutics AS will host a global investor call today in English to discuss matters related to its ongoing warrants exercise program, with the session led by the company’s CEO, CFO, and CBO. The presentation materials for the event will be made available to investors through the company’s website, underscoring its efforts to engage the market and provide transparency during a key financing-related process.
More about EXACT Therapeutics AS
EXACT Therapeutics AS is a clinical-stage precision medicine company that uses ultrasound to activate its proprietary drug PS101 and improve the effect of oncology treatments. The technology has a broad potential, as PS101 can be combined with multiple therapeutic agents in cancer and other indications, including brain diseases, and the company’s shares trade on Euronext Growth Oslo under the ticker EXTX.
Average Trading Volume: 33,364
Current Market Cap: NOK118.9M
For detailed information about 56F stock, go to TipRanks’ Stock Analysis page.